Ovarian Mucinous Neoplasms, Intestinal Type, in Premenopausal Patients, Develop in Abnormal Ovaries.
Sign Up to like & getrecommendations! Published in 2020 at "Human pathology"
DOI: 10.1016/j.humpath.2020.11.003
Abstract: Although several studies have addressed different aspects of the mucinous neoplasms arising in the ovary, such as their clinicopathologic features, immunohistochemical profile, and molecular characteristics, no study has presented an analysis of the ovarian tissue… read more here.
Keywords: neoplasms intestinal; ovarian tissue; premenopausal patients; mucinous neoplasms ... See more keywords
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare
Sign Up to like & getrecommendations! Published in 2023 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-2073-1887
Abstract: Abstract In patients with existing ovarian function, there are some special aspects to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-negative (HR pos./HER2 neg.) breast cancer. Treatment options include tamoxifen with or without… read more here.
Keywords: therapy premenopausal; her2; therapy; mit ... See more keywords
2022-RA-1389-ESGO Diagnostic accuracy of ultrasound O-RADS for classifying adnexal mass: systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.1136/ijgc-2022-esgo.174
Abstract: and patient’s age as variables, has been developed using a training dataset. This algorithm was named Risk of Ovarian Cancer Kazan Index (ROCK-I). The validating group consisted of 227 consecutively operated premenopausal patients with pelvic… read more here.
Keywords: rock; 2022 1389; rock roma; premenopausal patients ... See more keywords
Abstract PS5-09: Tumour infiltrating lymphocytes of prognostic value in different molecular breast cancer subgroups and as a suggestive predictive factor for adjuvant tamoxifen benefit in premenopausal patients after 30 years follow-up
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs20-ps5-09
Abstract: BACKGROUND The molecular breast cancer subgroups comprise diverse immune biology; for human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) and triple-negative breast cancer (TNBC) abundance of tumour infiltrating lymphocytes (TILs) have been shown… read more here.
Keywords: tamoxifen benefit; premenopausal patients; cancer; breast cancer ... See more keywords
Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus
Sign Up to like & getrecommendations! Published in 2021 at "Lupus"
DOI: 10.1177/09612033211005067
Abstract: Objective To investigate the mechanism underlying systemic lupus erythematosus (SLE)-related bone loss by evaluating the bone mineral density (BMD) and bone turnover markers (BTMs) in premenopausal patients with new-onset SLE without any treatment. Methods BMD… read more here.
Keywords: patients new; premenopausal patients; bone; onset sle ... See more keywords
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
Sign Up to like & getrecommendations! Published in 2018 at "BMC Cancer"
DOI: 10.1186/s12885-018-4843-2
Abstract: BackgroundSeveral trials evaluated the role of ovarian function suppression for the adjuvant treatment of premenopausal patients with hormone receptor-positive early breast cancer. Based on the results of the SOFT and TEXT trials, international guidelines recommend… read more here.
Keywords: treatment; consensus; premenopausal patients; breast cancer ... See more keywords
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.21.02844
Abstract: PURPOSE To assess the long-term (20-year) endocrine therapy benefit in premenopausal patients with breast cancer. METHODS Secondary analysis of the Stockholm trial (STO-5, 1990-1997) randomly assigning 924 premenopausal patients to 2 years of goserelin (3.6… read more here.
Keywords: year; risk patients; goserelin tamoxifen; tamoxifen ... See more keywords